APA (7th ed.) Citation

Blanco, J., Alejos, B., & Moreno, S. (2020). Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2). PLoS ONE, 15(1), 1. https://doi.org/10.1371/journal.pone.0226724

Chicago Style (17th ed.) Citation

Blanco, Jose-Ramon, Belen Alejos, and Santiago Moreno. "Immune Recovery Markers in a Double Blind Clinical Trial Comparing Dolutegravir and Raltegravir Based Regimens as Initial Therapy (SPRING-2)." PLoS ONE 15, no. 1 (2020): 1. https://doi.org/10.1371/journal.pone.0226724.

MLA (9th ed.) Citation

Blanco, Jose-Ramon, et al. "Immune Recovery Markers in a Double Blind Clinical Trial Comparing Dolutegravir and Raltegravir Based Regimens as Initial Therapy (SPRING-2)." PLoS ONE, vol. 15, no. 1, 2020, p. 1, https://doi.org/10.1371/journal.pone.0226724.